These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28502078)

  • 1. Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.
    Ito D; Yogosawa S; Mimoto R; Hirooka S; Horiuchi T; Eto K; Yanaga K; Yoshida K
    Cancer Sci; 2017 Aug; 108(8):1565-1573. PubMed ID: 28502078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
    Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
    PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.
    Yamaguchi N; Mimoto R; Yanaihara N; Imawari Y; Hirooka S; Okamoto A; Yoshida K
    Tumour Biol; 2015 Aug; 36(8):5913-23. PubMed ID: 25712377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enforced dual-specificity tyrosine-regulated kinase 2 expression by adenovirus-mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer.
    Imaizumi Y; Yoshida S; Kanegae Y; Eto K; Yoshida K
    Cancer Sci; 2022 Mar; 113(3):960-970. PubMed ID: 34932844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer.
    Kumamoto T; Yamada K; Yoshida S; Aoki K; Hirooka S; Eto K; Yanaga K; Yoshida K
    Int J Oncol; 2020 Jun; 56(6):1529-1539. PubMed ID: 32236621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
    Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
    Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer.
    Imawari Y; Mimoto R; Hirooka S; Morikawa T; Takeyama H; Yoshida K
    Cancer Sci; 2018 Feb; 109(2):363-372. PubMed ID: 29193658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.
    Mimoto R; Taira N; Takahashi H; Yamaguchi T; Okabe M; Uchida K; Miki Y; Yoshida K
    Cancer Lett; 2013 Oct; 339(2):214-25. PubMed ID: 23791882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Zhang D; Zhao L; Shen Q; Lv Q; Jin M; Ma H; Nie X; Zheng X; Huang S; Zhou P; Wu G; Zhang T
    Int J Cancer; 2017 May; 140(10):2298-2309. PubMed ID: 28213952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.
    Yokoyama-Mashima S; Yogosawa S; Kanegae Y; Hirooka S; Yoshida S; Horiuchi T; Ohashi T; Yanaga K; Saruta M; Oikawa T; Yoshida K
    Cancer Lett; 2019 Jun; 451():100-109. PubMed ID: 30851422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma.
    Harada E; Yoshida S; Imaizumi Y; Kawamura A; Ohtsuka T; Yoshida K
    Biochim Biophys Acta Gen Subj; 2024 Jun; 1868(6):130600. PubMed ID: 38508285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Tang B; Liang W; Liao Y; Li Z; Wang Y; Yan C
    Oncol Rep; 2019 Jan; 41(1):43-56. PubMed ID: 30365128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
    Hashimoto M; Kobayashi T; Tashiro H; Arihiro K; Kikuchi A; Ohdan H
    Int J Cancer; 2016 Aug; 139(4):812-23. PubMed ID: 27037526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.
    Yamashita S; Chujo M; Tokuishi K; Anami K; Miyawaki M; Yamamoto S; Kawahara K
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1303-8. PubMed ID: 19818968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy.
    Nomura S; Suzuki Y; Takahashi R; Terasaki M; Kimata R; Terasaki Y; Hamasaki T; Kimura G; Shimizu A; Kondo Y
    BMC Urol; 2015 Jun; 15():53. PubMed ID: 26087959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
    Gao T; Wang M; Xu L; Wen T; Liu J; An G
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.